Intracellular Th (ITCI) Insider Trading
- $36,135,587.62
- $161,248,218.30
- Nov. 12, 2024
- Sharon Mates
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 12, 2024 | President | 22,869 | $89.12 | Sell | $2,038,085.28 | |
Aug. 30, 2024 | CEO | 34,396 | $72.84 | Sell | $2,505,404.64 | |
Aug. 27, 2024 | CEO | 40,513 | $73.58 | Sell | $2,980,946.54 | |
Aug. 23, 2024 | CEO | 28,680 | $74.46 | Sell | $2,135,512.80 | |
Aug. 21, 2024 | CEO | 53,013 | $75.65 | Sell | $4,010,433.45 | |
Aug. 16, 2024 | EVP | 18,714 | $75.08 | Sell | $1,405,047.12 | |
June 24, 2024 | Director | 4,462 | $75.57 | Sell | $337,193.34 | |
June 18, 2024 | Director | 20,000 | $75.91 | Sell | $1,518,200.00 | |
March 11, 2024 | CFO | 10,121 | $65.96 | Sell | $667,581.16 | |
March 11, 2024 | EVP | 7,345 | $65.97 | Sell | $484,549.65 | |
March 11, 2024 | CEO | 20,565 | $65.21 | Sell | $1,341,043.65 | |
March 7, 2024 | CEO | 40,712 | $66.50 | Sell | $2,707,348.00 | |
March 7, 2024 | CFO | 13,132 | $66.60 | Sell | $874,591.20 | |
March 7, 2024 | EVP | 6,450 | $66.56 | Sell | $429,312.00 | |
Feb. 26, 2024 | EVP | 7,907 | $69.53 | Sell | $549,773.71 | |
Feb. 26, 2024 | CFO | 13,337 | $69.43 | Sell | $925,987.91 | |
Feb. 26, 2024 | CEO | 22,590 | $69.79 | Sell | $1,576,556.10 | |
Feb. 26, 2024 | Director | 26,328 | $68.68 | Sell | $1,808,207.04 | |
Jan. 18, 2024 | CEO | 67,917 | $65.19 | Sell | $4,427,509.23 | |
Jan. 16, 2024 | CEO | 75,361 | $67.25 | Sell | $5,068,027.25 | |
Jan. 11, 2024 | EVP | 50,000 | $66.83 | Sell | $3,341,500.00 | |
Jan. 2, 2024 | EVP | 62,282 | $70.60 | Sell | $4,397,109.20 | |
Dec. 13, 2023 | EVP | 21,262 | $65.00 | Sell | $1,382,030.00 | |
Nov. 6, 2023 | EVP | 42,393 | $55.63 | Sell | $2,358,322.59 | |
Sept. 18, 2023 | CEO | 55,587 | $53.76 | Sell | $2,988,357.12 | |
Aug. 7, 2023 | EVP | 55,300 | $58.79 | Sell | $3,251,087.00 | |
July 17, 2023 | EVP | 1,842 | $65.00 | Sell | $119,730.00 | |
June 14, 2023 | CFO | 81,854 | $63.97 | Sell | $5,236,200.38 | |
April 17, 2023 | Director | 10,000 | $63.00 | Sell | $630,000.00 | |
March 28, 2023 | EVP | 15,604 | $54.31 | Sell | $847,453.24 | |
March 13, 2023 | EVP | 7,344 | $45.04 | Sell | $330,773.76 | |
March 13, 2023 | CEO | 20,565 | $44.99 | Sell | $925,219.35 | |
March 13, 2023 | CFO | 5,582 | $44.93 | Sell | $250,799.26 | |
March 10, 2023 | CEO | 41,770 | $43.15 | Sell | $1,802,375.50 | |
March 10, 2023 | EVP | 8,550 | $43.34 | Sell | $370,557.00 | |
March 10, 2023 | CFO | 15,663 | $43.06 | Sell | $674,448.78 | |
March 1, 2023 | EVP | 7,241 | $50.01 | Sell | $362,122.41 | |
Feb. 24, 2023 | SVP | 7,906 | $47.14 | Sell | $372,688.84 | |
Feb. 24, 2023 | CEO | 22,590 | $47.03 | Sell | $1,062,407.70 | |
Feb. 24, 2023 | EVP | 4,046 | $47.12 | Sell | $190,647.52 | |
Feb. 24, 2023 | CFO | 7,455 | $47.03 | Sell | $350,608.65 | |
Feb. 21, 2023 | SVP | 8,354 | $46.84 | Sell | $391,301.36 | |
Feb. 21, 2023 | CEO | 27,848 | $46.83 | Sell | $1,304,121.84 | |
Feb. 21, 2023 | EVP | 3,898 | $47.01 | Sell | $183,244.98 | |
Feb. 21, 2023 | CFO | 10,443 | $46.82 | Sell | $488,941.26 | |
Feb. 17, 2023 | CFO | 53,968 | $49.83 | Sell | $2,689,225.44 | |
Dec. 19, 2022 | Director | 5,000 | $50.82 | Sell | $254,100.00 | |
Dec. 13, 2022 | CEO | 33,083 | $55.00 | Sell | $1,819,565.00 | |
Dec. 1, 2022 | EVP | 50,000 | $53.73 | Sell | $2,686,500.00 | |
Sept. 21, 2022 | CFO | 65,164 | $45.63 | Sell | $2,973,433.32 |
Insiders are both buying and selling Intracellular Th stock.
The insider traders at Intracellular Th are: Sharon Mates, Mark Neumann, Lawrence J Hineline, Michael Halstead, Christopher D Alafi, Suresh K Durgam, Lawrence J. Hineline, Joel S Marcus, Lawrence P Wennogle, Alafi Capital Co Llc, Kimberly E Vanover, Rory B Riggs, Nostrand Robert L Van, Suresh K. Durgam, Robert E Davis, Richard A Lerner, Christopher D. Alafi, Andrew Satlin, and Moshe Alafi
The most active insider trader at Intracellular Th is Sharon Mates with 35 trades.
Sharon Mates has sold the most Intracellular Th stock with a total value of $58,012,058.42.
Christopher D Alafi has bought the most Intracellular Th stock with a total value of $31,960,524.48.
The most recent insider trade for Intracellular Th was on Nov. 12, 2024.
The single biggest insider buy for Intracellular Th was from Christopher D Alafi with a total value of $15,000,000.00 on March 11, 2015.
The single biggest insider sell for Intracellular Th was from Michael Halstead with a total value of $8,411,604.28 on Dec. 21, 2021.